Understanding those effects could help guide how we approach prevention and treatment of AFib in the future. This single-center, retrospective study looked at 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024
there is no evidence of CV benefit with lixisenatide
ZhouJLuPHeHZhangRYangDLiuQet al
Frontiers in Endocrinology, 14 , 1215356
These features include deficits in social interaction, impaired communication, and repetitive behavior, which were evaluated by three chamber testing, ultrasound vocalization (USV) testing, and self-grooming testing, respectively
If you've been running on the treadmill three times a week for six months, your body knows that workout